Night-Time Antihypertensive Dosing: A Personalized Strategy, Not a Universal Recommendation

Announcing a new article publication for Cardiovascular Innovations and Applications which challenges the idea that taking blood pressure medication at bedtime is beneficial for everyone.

In “Night-Time Antihypertensive Dosing: A Personalized Strategy, Not a Universal Recommendation,” researchers Nurul Nabilah Rohaimin and Rajan Rajabalaya from Universiti Brunei Darussalam examine clinical evidence showing that bedtime dosing may improve night-time blood pressure control but does not consistently reduce cardiovascular events.

The authors advocate a personalized approach, considering individual blood pressure patterns, medication characteristics, sleep routines, and patient safety rather than recommending universal bedtime dosing.

The commentary highlights the importance of tailoring hypertension treatment to individual patient needs and calls for further research into personalized medication timing.

Read more: https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2026.0027

# # # # # #

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Nurul Nabilah Rohaimin and Rajan Rajabalaya. Night-Time Antihypertensive Dosing: A Personalized Strategy, Not a Universal Recommendation. CVIA. 2026. Vol. 11(1). DOI: 10.15212/CVIA.2026.0027